Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥3.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Operating income−¥90m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥120m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥70m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥305m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥69m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥69m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥8.4bnat 2023-09-30Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.8bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥664mat 2023-09-30Cons.Liabilities
Total liabilities¥781mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥7.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥141m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥61m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥541m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥483m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥485m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.132023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.622022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.822022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.312022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio90.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m
Reconciling Itemsreconcilingsegment ordinary income2022-04-01 → 2022-09-30−¥286m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥674m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥674m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2022-04-01 → 2022-09-30¥222m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥903m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥903m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2022-04-01 → 2022-09-30¥134m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.6bn
—segment totalsegment ordinary income2022-04-01 → 2022-09-30¥356m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 486
ItemContextValueUnit
Comprehensive incomePrior1YTDDuration57932000JPY
Comprehensive incomeCurrentYTDDuration169220000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration57932000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration169220000JPY
Income before income taxesPrior1YTDDuration70118000JPY
Income before income taxesCurrentYTDDuration61926000JPY
Amortization of goodwill ope cfPrior1YTDDuration1356000JPY
Amortization of goodwill ope cfCurrentYTDDuration1356000JPY
Depreciation and amortization ope cfPrior1YTDDuration21829000JPY
Depreciation and amortization ope cfCurrentYTDDuration16264000JPY
Share based compensation expenses ope cfPrior1YTDDuration29099000JPY
Share based compensation expenses ope cfCurrentYTDDuration25979000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-13004000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-6909000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration1252000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-237000JPY
Subsidy income ope cfPrior1YTDDuration-98730000JPY
Subsidy income ope cfCurrentYTDDuration-204772000JPY
Interest income ope cfPrior1YTDDuration-16453000JPY
Interest income ope cfCurrentYTDDuration-23921000JPY
Interest expenses ope cfPrior1YTDDuration80000JPY
Interest expenses ope cfCurrentYTDDuration-JPY
Loss gain on investments in partnership ope cfPrior1YTDDuration-14156000JPY
Loss gain on investments in partnership ope cfCurrentYTDDuration720000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration688000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration2404000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-7526000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration-39798000JPY
Loss gain on valuation of investment securities ope cfPrior1YTDDuration-JPY
Loss gain on valuation of investment securities ope cfCurrentYTDDuration8349000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-138612000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration134313000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-96228000JPY
Decrease increase in inventories ope cfCurrentYTDDuration20447000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration86975000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-74879000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-23324000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-89851000JPY
Increase decrease in other current liabilities ope cfPrior1YTDDuration174683000JPY
Increase decrease in other current liabilities ope cfCurrentYTDDuration-2665000JPY
Other net ope cfPrior1YTDDuration35715000JPY
Other net ope cfCurrentYTDDuration2690000JPY
Subtotal ope cfPrior1YTDDuration13762000JPY
Subtotal ope cfCurrentYTDDuration-168582000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration16453000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration23921000JPY
Proceeds from subsidy ope cfPrior1YTDDuration32730000JPY
Proceeds from subsidy ope cfCurrentYTDDuration204772000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-80000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass